Literature DB >> 13854847

Basal and supplemental blood pressures in relationship to life expectancy and hypertension symptomatology.

F H SMIRK, A M VEALE, K S ALSTAD.   

Abstract

Entities:  

Keywords:  HYPERTENSION; LIFE EXPECTANCY

Mesh:

Year:  1959        PMID: 13854847

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


× No keyword cloud information.
  12 in total

1.  The use of successive blood-pressure measurements to estimate blood-pressure variability.

Authors:  M S Glasgow; B T Engel; B C D'Lugoff
Journal:  J Behav Med       Date:  1988-10

2.  Criteria for return to work. Case study of hypertensives.

Authors:  E K Chook
Journal:  Int Arch Arbeitsmed       Date:  1970

3.  The effect of once daily beta-adrenoceptor blocker-thiazide diuretic combination on the ambulatory blood pressure.

Authors:  B A Gould; R S Hornung; H Kieso; S Mann; E B Raftery
Journal:  Br J Clin Pharmacol       Date:  1982-12       Impact factor: 4.335

4.  Blood pressures that fall on rechecking.

Authors:  D G Beevers
Journal:  Br Med J (Clin Res Ed)       Date:  1982-01-09

5.  Once daily beta-adrenoceptor blockade in hypertension: an ambulatory assessment.

Authors:  S Mann; M W Craig; V Balasubramanian; E B Raftery
Journal:  Br J Clin Pharmacol       Date:  1981-08       Impact factor: 4.335

6.  Prognosis of treated hypertension 1951-1981.

Authors:  C J Bulpitt
Journal:  Br J Clin Pharmacol       Date:  1982-01       Impact factor: 4.335

7.  Labile hypertension and jogging: new diagnostic tool or spurious discovery?

Authors:  W Fitzgerald
Journal:  Br Med J (Clin Res Ed)       Date:  1981-02-14

8.  CAUSES OF DEATH IN TREATED HYPERTENSIVE PATIENTS: BASED ON 82 DEATHS DURING 1959-61 AMONG AN AVERAGE HYPERTENSIVE POPULATION AT RISK OF 518 PERSONS.

Authors:  H SMIRK; J V HODGE
Journal:  Br Med J       Date:  1963-11-16

9.  24 h blood pressure control with the once daily calcium antagonist, amlodipine.

Authors:  M E Heber; G Brigden; I Al-Khawaja; E B Raftery
Journal:  Br J Clin Pharmacol       Date:  1989-03       Impact factor: 4.335

Review 10.  White-coat hypertension should not be treated in subjects with diabetes.

Authors:  Michael Bursztyn; Iddo Z Ben-Dov
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.